Avastin Added To Tarceva/Gemcitabine Fails To Prolong Survival In Phase III Pancreatic Cancer Trial
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche-sponsored trial did not meet the primary endpoint of overall survival, but did show some clinical benefits.